CAMBRIDGE, MA, Knome, a Cambridge-based life science company that specializes in the interpretation and comparison of human genomes, has raised $5 million in venture capital, according to a filing with the SEC.

Knome was founded in 2007 by a team of individuals who shared a belief in the potential of human genomics to fundamentally transform health and medicine. Led by George Church, Professor of Genetics at Harvard Medical School, Knome was the first organization to provide human whole genome analysis services on a commercial basis, beginning operations shortly after James Watson and Craig Venter became the first humans to be fully sequenced.